This report draws together the findings from the series of reports and briefing papers produced under the Beckley Foundation Drug Policy Programme in the last 18 months. It concludes that there are significant limitations in the achievements and likely future progress of current drug policies that focus on supply reduction and law enforcement, but that there is much that governments and international agencies can do to address the consequences of widespread drug use amongst their citizens.
- Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply
- How diverse is Canada’s legal cannabis industry? Examining race and gender of its executives and directors
- Coca and Its medical applications: Prospects, obstacles and lessons learned
- Funding what is possible. Robert Carr fund annual report 2019.
- The impact of arrest and seizure on drug crime and harms: A systematic review
- Addressing stigma and discrimination in the COVID-19 response
- Tackling the world's fastest-growing HIV epidemic: More efficient HIV responses in Eastern Europe and Central Asia
- IDPC Progress Report 2019-2020
- Reforming drug policies to reduce the trafficking and exploitation of vulnerable people